New causes of chronic pancreatitis;Les nouvelles causes de pancréatite chronique

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 5 SUPPL., 2002, Pages

  Hammel, Pascal ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CHRONIC PANCREATITIS; EOSINOPHILIA; GENE MUTATION; HUMAN; INFLAMMATORY DISEASE; PATHOGENESIS; RADIATION SICKNESS; REVIEW; CHRONIC DISEASE; DOMINANT GENE; ENTERITIS; GENETIC DISORDER; GENETICS; MUTATION; PANCREATITIS; PATHOLOGY; RADIOTHERAPY; RECESSIVE GENE; RISK FACTOR;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; EOSINOPHILIA; GENES, DOMINANT; GENES, RECESSIVE; GENETIC DISEASES, INBORN; HUMAN; INFLAMMATORY BOWEL DISEASES; MUTATION; PANCREATITIS; RADIOTHERAPY; RISK FACTORS; HUMANS;

EID: 2242445224     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Chronic pancreatitis: Diagnosis, classification and new genetic developments
2. The problem of classification and staging of chronic pancreatitis: Proposal based on current knowledge and its natural history
3. Idiopathic pancreatitis associated with inflammatory bowel disease
4. Chronic pancreatitis and inflammatory bowel disease: True or coincidental association?
5. Acute pancreatitis as a complication of Crohn's disease
6. Pancréatotoxicité des médicaments
7. The pancreas and inflammatory bowel diseases
8. Adverse events in patients treated with 5-aminosalicylic acid: 1993-1994 Pharmacovigilance report for Pentasa in France
9. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
10. Endoscopic and biopsy study of the upper gastrointestinal tract in Crohn's disease patients
11. High incidence of upper gastrointestinal involvement in Crohn's disease
12. Crohn's disease of the duodenum with spontaneous reflux into the pancreatic duct
13. Pancreatitis and duodenopancreatic reflux in Crohn's disease. Case report and review of the literature
14. Crohn's disease and pancreatitis
15. Duodenopancreatic fistula accompanying Crohn's disease of the distal duodenum
16. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease
17. Enterohepatic cycling of bilirubin: A putative mechanism for pigment gallstone formation in ileal Crohn's disease
18. Manifestations systémiques associées aux maladies inflammatoires chroniques de l'intestin
19. The pancreas as a site of granulomatous inflammation in Crohn's disease
20. Pancreatic changes in TNBS-induced colitis in mice
21. Case report of the Massachussetts General Hospital
22. Jaundice caused by a pancreatic mass
23. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease
24. Pancreatic function in chronic inflammatory bowel disease
25. Pancreatic function in Crohn's disease
26. Hyperamylasemie, hyperlipasemie and acute pancreatitis in chronic inflammatory bowel diseases
27. Hyperamylasemia in inflammatory bowel disease
28. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease
29. Pancreatic autoantibodies in Crohn's disease: A family study
30. Characterization of antigens from the human exocrine pancreatic tissue relevant as target antigens for autoantibodies in Crohn's disease
31. Acute pancreatitis in Crohn's disease
32. Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies
33. Pancréatite aiguë subintrante révélant une maladie de Crohn et régressant sous corticothérapie
34. Chronic inflammatory sclerosis of the pancreas: An autonomous pancreatic disease?
35. Chronic pancreatitis caused by an autoimmune abnormality
36. Non-alcoholic duct destructive chronic pancreatitis
37. Sclerosing pancreato-cholangitis responsive to steroid therapy
38. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: Report of two case reports and review
39. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy
40. Autoimmune pancreatitis: Radiologic findings in three histologically proven cases
41. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: A case report and review of the japanese literature
42. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response
43. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis
44. Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis
45. First report of association of chronic pancreatitis, primary biliary cirrhosis, and systemic sclerosis
46. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings
47. The gastrointestinal manifestations of Sjögren's syndrome
48. Identification of autoantibodies to a pancreatic antigen in patients with idiopathic chronic pancreatitis and Sjögren's syndrome
49. Pancreatic involvement in patients with Sjogren's syndrome and primary biliary cirrhosis
50. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome
51. T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice
52. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: A spontaneous model for Sjögren's syndrome
53. CD4+ T cells play an important role in acute experimental pancreatitis in mice
54. Autoimmune pancreatitis, pancreatic mass, and lower intestinal bleed
55. Clinical analysis of autoimmune-related pancreatitis
56. Autoimmune pancreatitis: CT and MR characteristics
57. Multiple pancreatic masses associated with autoimmunity
58. Autoimmune pancreatitis simulating pancreatic lymphoma
59. Autoimmune pancreatitis detected as a mass in the tail of the pancreas
60. FDG-PET of autoimmune-related pancreatitis: Preliminary results
61. Autoimmune pancreatitis detected as a mass in the head of the pancreas with contiguous fibrosis around the superior mesenteric artery
62. Anti-lactoferrin antibodies and other types of ANCA in Crohn's disease, ulcerative colitis, and primary sclerosing cholangitis
63. High serum IgG4 concentrations in patients with sclerosing pancreatitis
64. La pancréatite à éosinophiles: Une manifestation rare de l'allergie digestive?
65. Eosinophilic pancreatitis mimicking pancreatic neoplasia: EUS and ERCP findings - Is non surgical diagnosis possible?
66. Ictère révélant une atteinte pancréatique au cours d'un syndrome hyperéosinophilique idiopathique
67. Atteinte pancréatique, ascite et diarrhée au cours d'un syndrome hyperéosinophilique idiopathique
68. Eosinophilic granuloma of the gastrointestinal tract. Case report and suggested classification
69. Pancreatitis and eosinophilic gastroenteritis
70. Eosinophilic infiltrition of duodenum and pancreatic head: Report of a case studied arteriographically
71. Tumeur à éosinophiles du duodénum et du pancréas. A propos d'un cas
72. Eosinophilic pancreatitis: Report of a case
73. A case of chronic pancreatitis with eosinophilic pleural effusion
74. Eosinophilic gastroenteritis presenting with acute pancreatitis
75. Pancréatite à éosinophiles: Savoir y penser
76. Eosinophilic pancreatitis: A rare entity that can mimic a pancreatic neoplasm
77. Common bile duct stenosis with hypereosinophilia and pancreatitis in childhood: Report of two cases
78. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
79. The hereditary pancreatitis gene maps to long arm of chromosome 7
80. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis
81. Determination of the relative contribution of three genes - The cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene - to the etiology of idiopathic chronic pancreatitis
82. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis
83. Mutations of the cationic trypsinogen in chronic pancreatitis
84. Mutations of cationic trypsinogen in chronic pancreatitis
85. Mutations in the cationic trypsinogen gene and evidence for heterogeneity in hereditary pancreatitis
86. SPINK1/PSTI polymorphisms act as a disease modifiers in familial and idiopathic chronic pancreatitis
87. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis
88. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis
89. Clinical and genetic characteristics of patients with hereditary pancreatitis in Europe
90. Risk factors for cancer in hereditary pancreatitis
91. Pancreatitis and the risk of pancreatic cancer
92. Inherited predisposition to pancreatic cancer
93. A new polymorphism for the R122H mutation in hereditary pancreatitis
94. Mutations of the pancreatic secretory trypsin inhibitor gene in idiopathic chronic pancreatitis
95. Mutations of the pancreatic secretory inhibitor gene in idiopathic chronic pancreatitis
96. SPINK1 mutations in chronic pancreatitis
97. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis
98. The N34S mutation of PSTI (SPINK1) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease
99. Trypsin inhibitor (SPINK1/PSTI) mutations do not modify the penetrance or severity of hereditary pancreatitis
100. SPINK1 mutations are strongly associated with chronic pancreatitis
101. Pancreatitis and mutations of the cystic fibrosis gene
102. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations
103. Chronic pancreatitis and mutations of the cystic fibrosis gene
104. Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis
105. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
106. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
107. Prévalence des mutations du gène CFTR au cours des pancréatites chroniques idiopathiques
108. Mutation of PSTI and CFTR genes in patients with pancreatitis
109. Cystic: Fibrosis transmembrane regulator DF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer
110. Mucoviscidose reconnue après l'âge de 25 ans. Revue et devenir des cas de la littérature
111. Mucoviscidose de diagnostic tardif
112. La mucoviscidose à l'âge adulte en 1994
113. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
114. Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances
115. Abdominal radiotherapy is a cause for chronic pancreatitis
116. Histological findings in chronic pancreatitis after abdominal radiotherapy
117. Pancreatic carcinoma complicating chronic pancreatitis secondary to radiation for Wilm's tumor